Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ACO Success Depends On Optimal Medication Management – NPC

Executive Summary

A recent article funded by the National Pharmaceutical Council asserts that the success of value-based health care delivery models such as accountable care organizations will require viewing pharmaceuticals as a tool that can reduce total costs and improve quality, rather than a siloed expense.

You may also be interested in...



ACO Rx Survey Suggests Ways To Help Integrate Drug Use Into Care

A recent report finds many gaps in accountable care organizations’ abilities to support, monitor and ensure appropriate use of medications, and a group headed by the National Pharmaceutical Council aims to address them as it continues developing an ACO toolkit for medication management.

ACO Survey Shows Areas For Improvement In Drug Management

A number of opportunities exist for Medicare accountable care organizations to improve prescription drug management with patients, suggesting areas where drug manufacturers might want to offer support.

CMS Interested In Part D Plan Collaboration With Medicare ACOs

In a draft version of its annual instructions to Part D plans, CMS says it is seeking feedback from Part D sponsors and other stakeholders on “possible strategies for achieving better coordination” between stand-alone Medicare Part D plans and accountable care organizations to improve pharmacy care.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS054602

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel